Atlas Trials

Pandemic Influenza

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pandemic Influenza

RecordFirmDate
Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults (NCT01640691)Adimmune Corporation2012-07-10
Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India (NCT01053143)Sanofi Pasteur, a Sanofi Company2010-01-01
Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine (NCT00950456)Alachua Government Services, Inc.2009-11-01
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age (NCT00971542)Novartis Vaccines2009-09-01
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age (NCT00970177)Novartis Vaccines2009-08-01
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age (NCT00971906)Novartis Vaccines2009-08-01
A/H1N1 Immunogenicity and Safety in Adults (NCT00959465)Alachua Government Services, Inc.2009-08-01
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age (NCT00971100)Novartis Vaccines2009-08-01
A/H5N1/LT Dose Ranging Study (NCT00908687)Intercell USA, Inc.2009-05-01
Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine (NCT00535665)Sinovac Biotech Co., Ltd2007-09-01
A/H5N1 Dose Ranging Study With Adjuvant Patch (NCT00532792)Intercell USA, Inc.2007-08-01
Safety, Reactogenicity and Immunogenicity of an H5N1 VLP (NCT00519389)Novavax2007-07-01
Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine (NCT00660257)Sinovac Biotech Co., Ltd2007-01-01
A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza (NCT00640874)Kirby Institute
A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza (NCT00640302)Kirby Institute
A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B (NCT00640211)Kirby Institute

Track Pandemic Influenza automatically

Every clearance here is in the API, with alerts when new ones post.